1. Home
  2. WETO vs PROK Comparison

WETO vs PROK Comparison

Compare WETO & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WETO
  • PROK
  • Stock Information
  • Founded
  • WETO 2019
  • PROK 2015
  • Country
  • WETO China
  • PROK United States
  • Employees
  • WETO N/A
  • PROK N/A
  • Industry
  • WETO
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WETO
  • PROK Health Care
  • Exchange
  • WETO NYSE
  • PROK Nasdaq
  • Market Cap
  • WETO 88.0M
  • PROK 94.9M
  • IPO Year
  • WETO 2025
  • PROK N/A
  • Fundamental
  • Price
  • WETO $2.71
  • PROK $0.75
  • Analyst Decision
  • WETO
  • PROK Buy
  • Analyst Count
  • WETO 0
  • PROK 4
  • Target Price
  • WETO N/A
  • PROK $5.00
  • AVG Volume (30 Days)
  • WETO 2.0M
  • PROK 545.4K
  • Earning Date
  • WETO 01-01-0001
  • PROK 05-12-2025
  • Dividend Yield
  • WETO N/A
  • PROK N/A
  • EPS Growth
  • WETO N/A
  • PROK N/A
  • EPS
  • WETO N/A
  • PROK N/A
  • Revenue
  • WETO $5,350,773.00
  • PROK $306,000.00
  • Revenue This Year
  • WETO N/A
  • PROK $54.34
  • Revenue Next Year
  • WETO N/A
  • PROK N/A
  • P/E Ratio
  • WETO N/A
  • PROK N/A
  • Revenue Growth
  • WETO N/A
  • PROK N/A
  • 52 Week Low
  • WETO $1.50
  • PROK $0.46
  • 52 Week High
  • WETO $4.30
  • PROK $3.94
  • Technical
  • Relative Strength Index (RSI)
  • WETO N/A
  • PROK 46.79
  • Support Level
  • WETO N/A
  • PROK $0.68
  • Resistance Level
  • WETO N/A
  • PROK $0.81
  • Average True Range (ATR)
  • WETO 0.00
  • PROK 0.07
  • MACD
  • WETO 0.00
  • PROK -0.00
  • Stochastic Oscillator
  • WETO 0.00
  • PROK 29.31

About WETO WEBUS INTERNATIONAL LIMITED

Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: